DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$5.65
Tradestie Score
55
Market Cap
$354.59M
Analyst Upside
+174.3%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.73
|
$350.98M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.87
|
$341.56M | - | 61 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.39
|
$332.96M | - | 58 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.98
|
$328.62M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.80
|
$304.12M | - | 63 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$17.59
|
$297.23M | - | 54 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$28.42
|
$293.03M | - | 52 | Compare |
|
OMER
Omeros Corporation
|
$10.16
|
$281.75M | 9.0 | 50 | Compare |
|
DBVT
DBV Technologies S.A.
|
$17.70
|
$275.54M | - | 54 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.00
|
$275.13M | - | 55 | Compare |
More DMAC Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry